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sequence from a 0.18T Esaote scanner (40° FA, TR 50ms, TE 16ms, scan
time 10 minutes, resolution 0.7mm × 0.7mm × 0.8mm).
MRI was performed at baseline and 21 months later to assess cartilage
volume changes over time. The cartilage volume was estimated by a fully
automatic, computer-based process of segmentation.
To quantify the bone structure, initially a voxel classiﬁcation method
determines a region-of-interest (ROI) by segmenting the tibia bone and
from there extracting the trabecular bone. Figure 1 shows the segmented
tibia bone in light gray and the ROI in light green. From the ROI, a generic
set of 534 features is extracted by applying Gaussian derivatives at
multiple scales. The process captures the differential geometry structure
of the local intensities, potentially allowing analysis of the intricate
network of the trabecular bone anatomy.
In the next step, a machine learning approach using cross-validation
applies partial least squares feature extraction to identify the linear
combination of the features that best relate the tibia structure with
the volume cartilage loss. The features extracted are employed to train
the linear discriminant analysis (LDA) classiﬁer. The outcome is the
probability of rapid cartilage volume loss.
Fig. 1.
Fig. 2.
Results: By quantifying the bone structure, the framework predicted
the rapid/slow progressors with odds ratio of 2.38 (p < 0.05). Figure 2
shows the cartilage volume loss separated out by 2 and 3-quantiles of
the bone marker. The median of the subjects classiﬁed as slow and rapid
progressors was 1.6% and 4.4% per year respectively.
Conclusions: The investigation revealed that disease-related bone
structure characteristics were reﬂected in the low-ﬁeld MRI appearance.
Even though the individual trabeculae are not visible, the applied texture
analysis captured tissue changes and demonstrated the possibility
of automatically to predict the cartilage volume loss by analyzing
the tibia trabecular bone structure. In practical terms, the developed
quantiﬁcation can be applied to support experts in selecting patients in
longitudinal studies. The advantages of this approach are the use of low
cost MRI equipments and a fully automatic computer-based framework,
which allows scalability to large, multi-center studies.
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Purpose: Knee osteoarthritis (OA) is thought to be a slowly evolving
disease with glacial changes in cartilage morphology necessitating
trials of potential treatments lasting 1–2 years with evidence that
over 6 months change in cartilage is not detectable. In contrast to
cartilage, bone has the capacity to respond/adapt rapidly, such as after
fracture. Bone marrow lesions (BMLs) show evidence histologically of
bone damage or microfracture, and are related to malalignment, to pain
and to OA progression. BMLs have been shown to change in volume at
1 year follow-up. In patients for whom braces were given as treatment
at either 6 or 12 weeks after baseline, we tested whether BMLs change
in volume earlier than 1 year, suggesting they may provide evidence of
short term ﬂuctuations of joint damage.
Methods: In 30 patients with painful knee OA all of whom both met ACR
criteria for disease and had BMLs at baseline (11 Male, 19 Female, mean
age 54.8 yrs [SD 7.3], mean BMI 30.7 [SD 6.1]), we obtained baseline, 6
and 12 week knee MRI’s. To assess BML volume, axial PDW FS (TR 1500,
TE 15, FOV 14 cm, 256×256) and sagittal (3D WATSc (TR 20 TE7.7, FOV 15,
288×288) scans were obtained. We manually segmented BML volumes
for the whole knee using a strategy outlined (OARSI 2010) by MacLure et
al, testing repeatability of BML volumes in 5 knees remeasured. Using the
standard deviation of the difference between repeated measurements to
calculate Bland Altman limits of agreement as a gauge of measurement
error, we determined how much BML volume change represented a
change greater than due to chance
Test–retest reliability was high for the ﬁve scans measured repeatedly
(ICC =0.99, P < 0.0001) (mean difference = 108.1mm3, SD=106.7mm3)
The Bland-Altman 95% limits of agreement for rating differences,
assuming a zero-difference mean (no change in BML volume) were
−209.23 to +209.2mm3. To determine the proportion with BML change
greater than limits of agreement, we divided all knees into those with
any increase in BML volume vs. those with any decrease in volume.
Changes in knee BMLs at 6 and 12 weeks
Median (IQR) change in BML
Volume (mm3)
Proportion of knees with change
in BML volume > limits of
agreement
Knees with any INCREASE in
BML volume at 6 weeks
464.27 (107.02 to 685.63) 14/19
Knees with any DECREASE in
BML volume at 6 weeks
−640.05 (−1247.97 to −300.70) 9/11
Knees with any INCREASE in
BML volume at 12 weeks
514.32 (338.54 to 960.28) 14/18
Knees with any DECREASE in
BML Volume at 12 weeks
−738.73(−1497.36 to −103.96) 8/12
Results: In the 30 knees, median BML volume at baseline was
2,200.7mm3 (IQR 540.4mm3 to 4,627.7mm3). All knees showed at least
some change in BML volume by 6 and 12 weeks. As noted in the table, the
median increase from baseline to 6 weeks and from baseline to 12 weeks
was, in most knees, greater than the limits of agreement. For example,
of knees showing any increase in BML volume at 6 weeks, 14/19 (74%)
had changes greater than limits of agreement. For both increase and
decreasing BML’s, over 2/3’s of knees had such changes. Further, of the
30 knees studied, eight had at least 50% change in BML volumes at either
6 or 12 weeks.
Conclusion: Knee BML volumes change in several weeks in >2/3 of
persons with knee OA. To the extent that they could be regarded
as treatment targets, trials testing BML effects could avoid the usual
prolonged structure modiﬁcation trials.
